Abstract: The present invention relates to a conductive polymer or organic metal which is characterized in that nanoscopic particles formed from same with a particle size of less than 100 nm have an anisotropic morphology which is not spherical and has a length-to-diameter (“L/D”) ratio greater than 1.2. The invention also relates to a process for the preparation of such polymers and their use in the preparation of shaped parts, self-supporting foils or coatings with electrical conductivity, in particular on anisotropic substrates or in anisotropic media and fields.

Abstract: The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.

Abstract: An explosive device and methods for forming same, the device comprising a portion of nitrous oxide and a portion of fuel. In one example, the explosive device may include a first storage area containing said portion of nitrous oxide, and a second storage area containing said portion of fuel, wherein the first storage area selectively maintains the portion of nitrous oxide separated from the fuel in the second storage area prior to detonation of the explosive device. In another example, in the event the explosive fails to detonate, the explosive device may include a vent valve for discharging the nitrous oxide from the explosive device to reduce or eliminate its explosive characteristics. The explosive device can be used for various applications, including but not limited to military weapons, pyrotechnic devices, or civil blasting explosives, for example.

Abstract: A catalytic nanotemplate including a freestanding template particle and a director associated with the surface of the freestanding template particle. The free standing template particle may have multiple segments and the director may be associated with one or more of the segments. In instances where multiple segments are present, the segments may be made of different materials or be of the same material in different forms. More than one type of director or no director may be associated with any particular segment.

Abstract: There is provided an HSV Complex which comprises an avirulent HSV and a targeting agent which allows the HSV particle to infect and lyse a specific targeted cell. The inventors have found a way in which avirulent HSV can be targeted to disease cells, e.g. cancer cells, by incorporating an antibody binding domain into one or more viral glycoproteins.

Abstract: Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.

Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a device that forms drug containing aerosols for use in inhalation therapy. In a device aspect of the present invention, a device for delivering drug containing aerosols for inhalation therapy is provided. The device includes a housing and an airway that has a gas/vapor mixing airway. The airway further includes a subassembly, which has a metallic substrate coated on its surface with a composition comprising a drug.

Abstract: Certain embodiments of the methods and compositions of matter disclosed herein relate to: “simultaneous” control of rodents and at least one insect pest (e.g., cockroach, ant, tick) using the same bait; control of ticks by orally administering to mammals a diet composition comprising fipronil; enhancing insecticide efficacy through use of a diet composition that comprises a Generation-I rodenticide and an insecticide; use of imidacloprid in a diet composition orally administerable to mammals in an uncontrolled setting; and use of at least one insecticide to enhance the efficacy of a rodenticide.

Abstract: The present invention relates to an anode for electroplating, which has an anode base and a shield and is characterized in that additive degradation is reduced when it is used in electroplating.

Abstract: This invention discloses a method for preparing a complex comprised of a PDGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a PDGF Nucleic Acid Ligand by SELEX methodology and associating the PDGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more PDGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a PDGF Nucleic Acid Ligand or Complex and methods for making the same.

Abstract: The present invention relates to the use of compounds that enhance H3-histamine receptor activity, or activation (e.g. H3-histamine receptor agonists) for the treatment of dyskinesia. The compounds are particularly useful for treating dyskinesia associated with parkinsonian therapy.

Abstract: High sparking initiator compositions with a controlled amount of power are disclosed. The initiator compositions comprise a metal containing oxidizing agent, at least one metal reducing agent, and a non-explosive binder. Low voltage igniters that provide bidirectional plumes upon ignition are also disclosed. These igniters have a electrically resistive element positioned across a hole in a support which directs the plume. These igniters and compositions are useful in the actuation of solid fuel heating unit, in particular, sealed heating units.

Abstract: An ambidextrous magazine release for a firearm is provided for a firearm having a magazine well configured to operatively receive a magazine having a side-locking recess received within the well. The ambidextrous magazine release comprises a linkage moveable between an engaged position and a disengaged position having a lock pin configured to be received in a side-locking recess of a magazine operatively received in the magazine well with the linkage in the engaged position and to clear the side-locking recess with the linkage in the disengaged position. An actuator is provided on the firearm comprising a bar having a opposing push surfaces extending between a right and left side of the firearm. An interface is provided between the linkage and actuator with the interface being configured so that as either of the opposing push surfaces of the bar is pushed by a user, the linkage is moved between the engaged and the disengaged position.

Abstract: Novel substituted phenylsulfur trifluorides that act as fluorinating agents are disclosed. Also disclosed are methods for their preparation and methods for their use in introducing one or more fluorine atoms into target substrate compounds. Finally, various intermediate compounds for use in preparing substituted phenylsulfur trifluorides are provided.

Abstract: A device for delivering a drug by inhalation is disclosed. The device includes a body defining an interior flow-through chamber having upstream and downstream chamber openings, and a drug supply unit contained within the chamber for producing, upon actuation, a heated drug vapor in a condensation region of the chamber. Gas drawn through the chamber region at a selected gas-flow rate is effective to form drug condensation particles from the drug vapor having a selected MMAD between 0.02 and 0.1 MMAD or between 1 and 3.5 ?m. A gas-flow control valve disposed upstream of the unit functions to limit gas-flow rate through the condensation region to the selected gas-flow rate. An actuation switch in the device activates the drug-supply unit, such that the drug-supply unit can be controlled to produce vapor when the gas-flow rate through the chamber is at the selected flow rate.